Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

New treatments focusing on immune pathways show promise for stubborn hair loss.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Hair follicles help skin immune recovery after UVB exposure.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Advanced human skin models improve drug development and could replace animal testing.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Hydrogels could lead to better treatments for wound healing without scars.